non-tuberculosis mycobacterial diseases/tuberculosis therapy (Shionogi)

N/A

Report date: 2025/03/20 09:42:49
NME

Base Information

Drug Namenon-tuberculosis mycobacterial diseases/tuberculosis therapy (Shionogi)
Drug Alias Namenon-tuberculosis mycobacterial diseases/tuberculosis therapy (Hsiri)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTuberculosisMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHsiri Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesHsiri Therapeutics Inc
Active IndicationsTuberculosisMycobacterium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A